Click Here
one more breath…
What’s New
Read about the treatment experiences of other pancreatic cancer patients, including what worked, the doctors or facilities they worked with, and more. Then share your story HERE.
Learn more about cutting-edge research in pancreatic cancer and gain insights from the scientists who are advancing new treatment options.
Read about the different drugs, new approaches, and latest developments in cutting-edge science being tested in active trials that are available to pancreatic cancer patients.
Educate yourself about pancreatic cancer and learn ways to make your life more comfortable during and after treatment. Find information on nutrition, exercise, and more to help you navigate life with pancreatic cancer.
Follow our up-to-the-minute newsfeed of the latest medical and scientific journal articles and abstracts related to pancreatic cancer.
The CanStem111P study (ClinicalTrials.gov Identifier: NCT02993731) included 1134 adults with treatment-naive, metastatic pancreatic adenocarcinoma who were randomly assigned to receive nab-paclitaxel and gemcitabine (569 patients) or napabucasin plus nab-paclitaxel and gemcitabine (565 patients). Read more . . .
Stay Connected
Join the conversation on our digital communities.
PancChat co-host Dr. Niraj Gusani has coauthored an article about the advantages of social media for oncology surgeons.
Let’s Win has reached its 5th anniversary. Read about our development and what we have accomplished in 5 short years.
Let’s Win has reached its 5th anniversary! Read our anniversary kickoff message to all our followers and supporters.
An affiliate of
In partnership with
